Skip to main content
logo
Becton, Dickinson and Company (VIE:BDX)
Austria flag Austria · Delayed Price · Currency is EUR
160.70
-2.50 (-1.53%)
At close: Oct 23, 2025

Revenue Breakdown

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 2011 - 2020
Medication Delivery Solutions Revenue
4.52B4.43B
Log In
Log In
Log In
Upgrade
Medication Management Solutions Revenue
3.44B3.30B
Log In
Log In
Log In
Upgrade
Pharmaceutical Systems Revenue
2.30B2.27B
Log In
Log In
Log In
Upgrade
Integrated Diagnostic Solutions Revenue
3.67B3.68B
Log In
Log In
Log In
Upgrade
Biosciences Revenue
1.47B1.51B
Log In
Log In
Log In
Upgrade
Surgery Revenue
1.54B1.49B
Log In
Log In
Log In
Upgrade
Peripheral Intervention Revenue
1.97B1.93B
Log In
Log In
Log In
Upgrade
Urology and Critical Care Revenue
1.60B1.55B
Log In
Log In
Log In
Upgrade
Revenue (Other)
880.00M9.00M
Log In
Log In
Log In
Upgrade
Revenue (Total)
21.39B20.18B
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 2011 - 2020
Medical Revenue
11.14B10.07B
Log In
Log In
Log In
Upgrade
Life Sciences Revenue
5.14B5.19B
Log In
Log In
Log In
Upgrade
Interventional Revenue
5.11B4.98B
Log In
Log In
Log In
Upgrade
Revenue (Total)
21.39B20.18B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 2011 - 2020
Medical Operating Income
2.71B2.74B
Log In
Log In
Log In
Upgrade
Life Sciences Operating Income
1.57B1.60B
Log In
Log In
Log In
Upgrade
Interventional Operating Income
1.53B1.42B
Log In
Log In
Log In
Upgrade
Operating Income (Other)
-3.06B-2.92B
Log In
Log In
Log In
Upgrade
Operating Income (Total)
2.75B2.84B
Log In
Log In
Log In
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai.